Policies · eGov

A review of Italy's digital health legal landscape covers AI governance, data protection, telemedicine, medical device software and market developments across the jurisdiction for 2026.
✦ AI SUMMARY 30-second read

- Italy's digital health market exceeded 4.6 billion euros in 2024, with social-care and territorial applications among the fastest-growing segments.
- Law No. 132 of 2025, in force since 10 October 2025, governs AI use in healthcare and requires AI systems to support rather than replace clinical decision-making.
- In September 2025, the State–Regions Conference approved a draft decree setting rules and security requirements for the National Telemedicine Platform.
Why it matters: Italy's expanding digital health ecosystem is being shaped by overlapping national and EU rules that affect providers, developers and patients alike.

This summary was generated by AI. Editors may review and update it.
Document details
| Document type | Rules & Regulation |
|---|---|
| Issued by | European Union |
| Region | Global |
| Published | 20 November 2026 |
Italy does not provide a statutory definition of digital health in its national law. For regulatory purposes, the term is understood to cover the use of information and communication technologies in healthcare for prevention, diagnosis, treatment and disease monitoring, consistent with the World Health Organization's framing, and extends to lifestyle and wellness technologies.

A 2025 analysis by NetConsulting cube found that Italy's digital health market exceeded 4.6 billion euros in 2024, up from nearly 4.2 billion euros the previous year. Social-care and territorial applications were the principal growth driver, rising from 54.8 to 375 million euros, while electronic health records grew fivefold from 69.3 to 375 million euros. Telemedicine grew from 46.8 to 70.7 million euros.
What the documents say
Digital health in Italy is governed by a layered framework of EU and national instruments. EU Regulations 2017/745 and 2017/746, together with national Decrees 137/2022 and 138/2022, cover medical devices and Software as a Medical Device. Personal data processing is regulated by the GDPR and the Italian Privacy Code, Legislative Decree No. 196/2003.
Law No. 132 of 2025, which came into force on 10 October 2025, transposes the EU AI Act principles into Italian law. Article 7 of that law specifically addresses healthcare, stating that AI systems constitute a support in prevention, diagnosis, treatment and therapeutic choice, with final decisions always resting with the medical professional. AI systems and the data they rely on must be reliable, periodically verified and updated to minimise errors and improve patient safety.
Cybersecurity obligations fall under Legislative Decree No. 138/2024, which transposed EU Directive 2022/2555 (NIS2). The National Cybersecurity Agency is responsible for protecting healthcare infrastructure from cyber-risks under that framework.
Who is affected
Principal regulatory oversight rests with the Ministry of Health, the Ministry of Economy and Finance, the Ministry of University and Research, and the Privacy Authority. The National Anti-Corruption Authority oversees anti-kickback rules governing financial relationships between healthcare workers and medical device companies.
Companies active in the market include Philips Healthcare, Reply, Dedalus Italia S.p.A., Healthware Group, Artexe S.p.A., Afea S.r.l., AlmavivA S.p.A. and Maticmind S.p.A. The ecosystem also includes numerous start-ups that have obtained support from larger organisations and from State and regional authorities.
Regional healthcare bodies retain influence over how national standards are applied in practice, producing some variation in the accessibility and governance of digital health solutions across Italy's regions.
Recent developments
In September 2025, the State–Regions Conference approved a draft decree establishing rules, a governance framework and security requirements for the National Telemedicine Platform, which is established within Agenas. On 14 October 2025, Agenas published two guidance documents to support the design, quality and interoperability of telemedicine services within that platform, one on telemonitoring and telecontrol and the other on televisits.
In July 2025, the Social Affairs Commission of the Chamber of Deputies presented a consolidated draft bill to establish a national committee within the Ministry of Health to guide the inclusion of Digital Therapeutics within the Essential Levels of Care.
What happens next
AIFA and the Ministry of Health have begun exploring more agile assessment frameworks suited to the evolving nature of AI and machine learning solutions, with efforts focused on real-world data, performance monitoring and post-market surveillance.
Identified areas requiring further attention include training healthcare professionals in digital health, managing patient and caregiver relationships in a digitised care environment, and building digital health literacy among patients and patient associations.